Thor Medical ASA (OSL:TRMED)
kr 1.018 0.014 (1.39%) Market Cap: 239.09 Mil Enterprise Value: 210.39 Mil PE Ratio: 0 PB Ratio: 0.93 GF Score: 39/100

Q2 2023 Thor Medical ASA Earnings Call Transcript

Aug 31, 2023 / 06:00AM GMT
Release Date Price: kr1.33 (-0.15%)
Ludvik Sandnes
Thor Medical ASA - Chairman of the Board

(foreign language) I'm pleased to be here to tell you about the [redirection] of Nordic Nanovector (inaudible). We're very proud that we have managed to get this deal in the first half of this year.

These are the highlights. As you will see, we had to close down PARADIGME and reduce cost to preserve the cash, the acquisition of Thor Medical, an emerging supplier of alpha-emitters. We managed to reach an agreement with as you accepted at the AGM on the 28th of June, and the transaction was closed just after the half of the year. And we are now strategic repositioning the company, which Alf Bjørseth will tell you more about. And then our new CFO, Brede Ellingsæter will come and tell you all about the financials.

I'm just here to present since I was the only one within the company. In the first half year, as you remember, there was an extraordinary General Meeting who elected a new Board. And then again, the Board prioritized to hire me as a former Chairman of the Board of the company. I knew the company. So we worked closely

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot